Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Genitourinary Cancers – Kidney / Bladder / Urothelial / Testicular
Categories
Alliance Committee
Browse by Year